Monthly Archives: December 2014

News – FDA Approves Lanreotide

On December 16, 2014, the U. S. Food and Drug Administration approved lanreotide (Somatuline® Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free … Continue reading

Posted in News & Resources | Tagged , , , , , , , , , | Leave a comment

Internationally Known Experts Spoke on Nov 15

Bea Lehming Memorial Lectures Brought International NET Experts to DC on November 15th In November, two internationally recognized experts addressed the Capitol Area Carcinoid Survivors Group. Thomas M. O’Dorisio, M.D. will speak on “Factors to consider in making treatment choices.” … Continue reading

Posted in Past Events | Leave a comment